Oral, Vaginal, Rectal

Oral, Vaginal, Rectal
Product Description

We offer millimeter solutions in medicine applicators and dispensers, being today a global reference for quality and precision in this segment.
Our systems aim to be used for oral, vaginal and rectal treatments such as Oral infections, Vaginal infections, and Rectal diseases.

Nemera

  • FR
  • 2015
    On CPHI since
  • 1
    Certificates
  • 1000 - 4999
    Employees
Company types
Manufacturer/Innovator

Nemera

  • FR
  • 2015
    On CPHI since
  • 1
    Certificates
  • 1000 - 4999
    Employees
Company types
Manufacturer/Innovator

More Products from Nemera (25)

  • Pen Vario

    Product Pen Vario

    Our portfolio of disposable pens includes variable and fixed dose devices for automatic and manual drug administration, combining modern design with high intuitiveness of use for multidose therapies.


    PENVARIO – Dedicated to manufacturing of disposable, variable-dose pen injectors
  • Reusable pens

    Product Reusable pens

    Our reusable pens ensure the application of proven technological solutions with reliability, intuitiveness as well as ease-of-use.
  • Autoinjectors & pens

    Product Autoinjectors & pens

    Proven track record in managing parenteral customized solution and large scale industrialization projects of Autoinjectors and Pens with top pharmaceutical companies.

    Our offer:

    - disposable & reusable pen injectors
    - Taylor-made autoinjectors & pens
  • Implanters

    Product Implanters

    Implants are fragile and insertion into the body requires caution. Nemera developed a portfolio of devices to deliver implants with integrated needlestick protection.

    There is two types of implanters:

    - Safety depot syringe with telescopic plunger rod
    - Safety retro injector for ...
  • Sof’Bag®+

    Product Sof’Bag®+

    Sof’Bag+ is an airless pouch-in-bottle packaging solution for prescription (Rx) and over-the-counter (OTC) formulations for dermal and transdermal application.
  • Sof’Airless XS+

    Product Sof’Airless XS+

    Sof’Airless XS+ is a protective mini-airless system for small dose applications and sampling.
    It is the solution for trial sizes or local treatments with very little skin surface to cover.
    It targets Rx and OTC dermal gels and creams and is already used for cold sore treatments.
  • RetroNose®: the pMDI concept device targeting nasal drug delivery through oral administration

    Product RetroNose®: the pMDI concept device targeting nasal drug delivery through oral administration

    With RetroNose®, enhance therapeutic efficacy of your nasal drug with a better deposition
  • Safe'n'Spray™: the smart electronic concept device with locking features

    Product Safe'n'Spray™: the smart electronic concept device with locking features

    Safe'n'Spray™: the integrated device with reusable electronic locking unit and fingerprint identification, to monitor drug delivered and prevent overdosing. Normal 0 21 false false false FR X-NONE X-NONE ...
  • Smart wearable to improve patients’ life.

    Product Smart wearable to improve patients’ life.

    Symbioze smart wearable platform is an innovative, large-volume on-body injector to foster patient’s adherence. It offers a great combination between design robustness, ease of use, connectivity, and sustainability, for a seamless and enhanced injection experience.
  • A spray for vaccine administration through the nasal route

    Product A spray for vaccine administration through the nasal route

    With our extensive experience in intranasal delivery, we offer reliable, easy to use and safe nasal vaccine solutions*. The concept device is constituted with a nozzle, a dose divider, and a luer lock syringe. It contains two-doses, allowing vaccine delivery for each nostril.
  • Disposable pens: tailor the injection

    Product Disposable pens: tailor the injection

    Our portfolio of disposable pens includes variable and fixed dose devices for automatic and manual drug administration, combining modern design with high intuitiveness of use for multidose therapies. Nemera offers three disposable pen injector development platforms with wide customization and drug capabil...
  • Implanters: Solutions for sustained released formulations

    Product Implanters: Solutions for sustained released formulations

    Implants are fragile and insertion into the body requires caution. Nemera developed a portfolio of devices to deliver implants with integrated needlestick protection. As implants can vary a lot, we support your projects and explore design attributes that will increase the user experience such as improved h...

Nemera resources (3)

  • News Nemera: Stronger than ever

    More modern, our new brand identity truly embodies who we are, how we partner with our customers and ultimately the value we bring to millions of patients across the world through our drug delivery device solutions.
  • Video Innovation in Connectivity Roundtable pt.1

    The Innovation in Connectivity Roundtable originally aired as part of Pharmapack Europe 2021 Part 1 of this session includes three presentations: Patient Journey Driven Considerations for Integrating Digital Health for Combination Products The importance of utilizing applied ethnography and other primary research methods to understand the patient journey as the foundation for integrating digital health into a device/combination product development initiative. Considering patient needs in the context of a larger ecosystem including providers, payers, and regulators to develop a robust plan with respect to connectivity and digital health. Examples of how this understanding is applied across the combination product development journey through organic development, utilization of platform devices, or as a lifecycle management enchantments while optimizing the user experience resulting in safe, effective, and differentiated combination products. Mark Tunkel, Global Category Director for Insight Innovation, Nemera Electronic Product Information: A Case Study on Medicine Labelling for the Visually Impaired The Electronic Product Information Initiative for Medicines (ePI) aim to ease the accessibility of product information to everyone, including visually impaired patients. The GS1 Digital Link aim to provide a single barcode for identification, brand protection, and access to product information for patients. Our lecture will illustrate how the existing Datamatrix on packaging could be leveraged, today, by everyone, including visually impaired users, to access a tailored and relevant information. Laurent Tonnelier, CEO, mobiLead - xTag Lise Wagner, Accessibility Specialist and User Expert, OKEENEA Traceability of Medicines: from Finished Product to Unit Dose Delivery Challenges for B2B Supply Chain stakeholders Regulations: a global overview What about B2C Nathalie Wardé, CEO & Founder, D4P pharma Join the above speakers and moderator Lionel Jeannin, Group Head Oral Packaging & Delivery Systems, Novartis Pharma AG for the live panel discussion that followed in the Innovation in Connectivity Roundtable pt. 2